Skip to content

Treatment with Swedana and Agnikarma in Cervical Spondylosis (Manyastambha)

A standard controlled clinical evaluation of Swedana and Agnikarma in cervical spondylosis (Manyastambha) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060502
Enrollment
60
Registered
2023-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M489- Spondylopathy, unspecified

Interventions

None listed

Sponsors

Uttarakhand Ayurved University,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient between the age of 20 to 60 years. 2.patient with classical sign and symptoms of cervical spondylosis. 3.Patient with less then 3 years of chronicity. 4.Patient fit and welling for Ruksha Baluka Swedana, Punnagadi Patra Potali Swedana, Agnikarma and Controlled drug.

Exclusion criteria

Exclusion criteria: 1.Patient with Congenital deformity, Traumatic injuries, Myelopathy, Ankylosing spondylosis, Infection of bone and Gross bony deformity. 2.Patient with uncontrolled HTN, Diabetes mellitus and other systemic disorder that interfere in the line of treatment. 3.Pregnancy and lactating mother. 4.Any neurological deficit.

Design outcomes

Primary

MeasureTime frame
No improvement: 0-25% Mild improvement:26-50% Moderate improvement:51-71% Marked improvement: 76-100% Timepoint: 0th, 16th day

Secondary

MeasureTime frame
Assessment of sign & symptomsTimepoint: 30 days

Countries

India

Contacts

Public ContactHarpreet singh

Rishikul Campus Haridwar

Kripayanam@yahoo.com9758264264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026